Literature DB >> 30780153

Pulmonary hypertension secondary to congenital diaphragmatic hernia: factors and pathways involved in pulmonary vascular remodeling.

Louise Montalva1,2, Lina Antounians1,2, Augusto Zani3,4.   

Abstract

Congenital diaphragmatic hernia (CDH) is a severe birth defect that is characterized by pulmonary hypoplasia and pulmonary hypertension (PHTN). PHTN secondary to CDH is a result of vascular remodeling, a structural alteration in the pulmonary vessel wall that occurs in the fetus. Factors involved in vascular remodeling have been reported in several studies, but their interactions remain unclear. To help understand PHTN pathophysiology and design novel preventative and treatment strategies, we have conducted a systematic review of the literature and comprehensively analyzed all factors and pathways involved in the pathogenesis of pulmonary vascular remodeling secondary to CDH in the nitrofen model. Moreover, we have linked the dysregulated factors with pathways involved in human CDH. Of the 358 full-text articles screened, 75 studies reported factors that play a critical role in vascular remodeling secondary to CDH. Overall, the impairment of epithelial homeostasis present in pulmonary hypoplasia results in altered signaling to endothelial cells, leading to endothelial dysfunction. This causes an impairment of the crosstalk between endothelial cells and pulmonary artery smooth muscle cells, resulting in increased smooth muscle cell proliferation, resistance to apoptosis, and vasoconstriction, which clinically translate into PHTN.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30780153     DOI: 10.1038/s41390-019-0345-4

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Early Left Ventricular Dysfunction and Severe Pulmonary Hypertension Predict Adverse Outcomes in "Low-Risk" Congenital Diaphragmatic Hernia.

Authors:  Duy T Dao; Neil Patel; Matthew T Harting; Kevin P Lally; Pamela A Lally; Terry L Buchmiller
Journal:  Pediatr Crit Care Med       Date:  2020-07       Impact factor: 3.624

Review 2.  Use of Prostaglandin E1 in the Management of Congenital Diaphragmatic Hernia-A Review.

Authors:  Srirupa Hari Gopal; Neil Patel; Caraciolo J Fernandes
Journal:  Front Pediatr       Date:  2022-07-01       Impact factor: 3.569

3.  A proteome signature of umbilical cord serum associated with congenital diaphragmatic hernia.

Authors:  Asuka Tachi; Yoshinori Moriyama; Hiroyuki Tsuda; Rika Miki; Takafumi Ushida; Mayo Miura; Yumiko Ito; Kenji Imai; Tomoko Nakano-Kobayashi; Masahiro Hayakawa; Fumitaka Kikkawa; Tomomi Kotani
Journal:  Nagoya J Med Sci       Date:  2020-05       Impact factor: 1.131

4.  Thoracoabdominal compartment syndrome complicating right-sided diaphragmatic eventration with co-existent unilateral renal agenesis.

Authors:  Sebastian Anebuokhae Omenai; Esther Opeyemi Adebowale; Ifeanyichukwu Dupe Nwanji
Journal:  Autops Case Rep       Date:  2020-04-02

Review 5.  Emerging antenatal therapies for congenital diaphragmatic hernia-induced pulmonary hypertension in preclinical models.

Authors:  Kathleen Marulanda; Nick D Tsihlis; Sean E McLean; Melina R Kibbe
Journal:  Pediatr Res       Date:  2020-10-10       Impact factor: 3.756

6.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

7.  Lung Metabolomics Profiling of Congenital Diaphragmatic Hernia in Fetal Rats.

Authors:  Maria Del Mar Romero-Lopez; Marc Oria; Miki Watanabe-Chailland; Maria Florencia Varela; Lindsey Romick-Rosendale; Jose L Peiro
Journal:  Metabolites       Date:  2021-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.